She was seen for two decades as a future face of the Democratic Party. Is she now suddenly a figure of its past?
The keys on my MacBook click in the quiet of my West Los Angeles apartment. I have not written an essay like this since ...
Ocular Therapeutix shifts Axpaxli's approval strategy, raising valuation risks and regulatory uncertainty. Click here to read ...